You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API gentamicin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing gentamicin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc PRED-G gentamicin sulfate and prednisolone acetate 0023-0066 CHLOROBUTANOL
Allergan Inc PRED-G gentamicin sulfate and prednisolone acetate 0023-0066 LANOLIN ALCOHOLS
Allergan Inc PRED-G gentamicin sulfate and prednisolone acetate 0023-0066 MINERAL OIL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for gentamicin

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: BUTYLPARABEN

Excipient focus: CHLOROBUTANOL

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE DISODIUM ANHYDROUS

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL MYRISTATE

Excipient focus: LANOLIN ALCOHOLS

Excipient focus: LIGHT MINERAL OIL

Excipient focus: METHYLPARABEN

Excipient focus: MINERAL OIL

Excipient focus: PETROLATUM

Excipient focus: POLYSORBATE 40

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLENE GLYCOL MONOPALMITOSTEARATE

Excipient focus: PROPYLENE GLYCOL MONOSTEARATE

Excipient focus: PROPYLPARABEN

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM METABISULFITE

Excipient focus: SODIUM PHOSPHATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC

Excipient focus: SORBITOL

Excipient focus: STEARIC ACID

Excipient focus: SULFURIC ACID

Excipient focus: TYLOXAPOL

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group